SEPOY.net
No Result
View All Result
Friday, June 13, 2025
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

An emerging target for chronic kidney disease treatment – DNA-PKcs

Nicholas by Nicholas
March 15, 2023
in Health
0
An emerging target for chronic kidney disease treatment – DNA-PKcs

Around 10% of the global population is affected by chronic kidney disease (CKD). The risk of CKD progressing into end-stage renal disease (ESRD) is exceptionally high, which requires dialysis or kidney transplantation. At present, there is no effective treatment for CKD is available. Hence, there is an urgent need to uncover the underlying pathological mechanisms of CKD to help formulate effective treatment strategies to prevent and cure the disease. A recent Nature Communications study suggested that DNA-PKcs could be a potential target for treating CKD.

READ ALSO

Prenatal exposure to forever chemicals linked to higher teen blood pressure

Meal and sleep timing play key roles in diabetes prevention

Study: DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives chronic kidney disease progression in male mice. Image Credit: crystal light / ShutterstockStudy: DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives chronic kidney disease progression in male mice. Image Credit: crystal light / Shutterstock

Background

An important pathological characteristic of CKD is renal interstitial fibrosis, associated with an unusual expression of profibrotic factors, such as transforming growth factor-beta 1 (TGF-β1), myofibroblast activation, and epithelial de-differentiation. TGF-β1 has a significant role in interstitial fibrosis that includes activation of fibrotic genes, such as fibronectin (FN), α-smooth muscle actin (α-SMA), and collagens. In addition, it is also associated with the Warburg effect-like metabolic reprogramming of kidney cells.

While analyzing the association between metabolic dysregulation and interstitial fibrosis, researchers observed metabolic reprogramming of kidney cells, i.e., myofibroblasts and renal tubular epithelial cells, during kidney injury. This occurrence influences the development of CKD.

During the metabolic reprogramming of kidney cells, a significant reduction in fatty acid oxidation (FAO) occurs along with a metabolic shift to glycolysis. These manifestations result in immune cell infiltration and interstitial fibrosis. Several animal models of renal fibrosis have shown that fibrosis attenuation is possible through glycolysis inhibition and FAO restoration using genetic or pharmacological approaches. 

DNA-dependent protein kinase (DNA-PK), which is a trimeric complex consisting of a catalytic subunit (DNA-PKcs) and a Ku70/80 heterodimer, is activated by reactive oxygen species (ROS) or DNA double-stranded breaks (DSBs). DNA-PK facilitates nonhomologous end joining (NHEJ) by connecting programmed DSBs, which is extremely important for lymphocyte recombination. Therefore, DNA-PKcs mutations inhibit the development of T and B lymphocytes. 

DNA-PKcs plays an essential role in various metabolic functions, such as phosphorylation of the transcription factor USF-1 that promotes fatty acid synthesis induced by insulin and metabolic deterioration during aging. In addition, a previous study revealed that DNA-PKcs regulates the target of rapamycin (mTOR) activation. Even though DNA damage response (DDR) has been linked to renal epithelial injury, little evidence has been documented about its role in epithelial de-differentiation and myofibroblast activation in progressive CKD. 

About the Study

The expression of DNA-PKcs was found to be increased in fibrotic kidneys, which progresses CKD development. The current study also revealed that DNA-PKcs expression was induced by TGFβ1-SMAD signaling, and DNA-PKcs knockout blocked SMAD2/SMAD3. These findings indicate a new pathway associated with TGFβ1-SMAD signaling activation in fibrosis.

A global prkdc gene-knockout mice model was developed and was used in this study. In vivo experiments using this mice model suggested that the elimination of DNA-PKcs resulted in attenuated renal tubular injury along with a reduction in the progression of renal interstitial fibrosis in unilateral ureteral obstruction (UUO) and unilateral ischemia-reperfusion (UIR) mouse models.

The current study failed to confirm whether DNA-PK promotes renal fibrosis independent of lymphocytes because lymphocyte deficiency is the most prominent phenotype of DNA-PKcs−/− mice. Therefore, to remove the effect of lymphocyte deficiency, the authors generated proximal renal tubular epithelial cells possessing specific DNA-PKcs knockout in vivo, using CRISPR/cas9 knock-in mice. 

a Metabolomics analysis of kidney tissues from each group as indicated. Heatmap image showing relative levels of metabolites in the glycolysis pathway, fatty acid metabolism and Krebs cycle in kidneys from each group (n = 4). Bars represent statistical analysis of representative metabolites in kidneys of each group (mean ± SD, n = 4 mice of each group). One-way ANOVA followed by Tukey’s multiple comparisons test was used to determine the p-values. b Working model (the template was created with BioRender.com) illustrating in which DNA-PKcs mediates activation of Raptor/mTORC1 signaling through phosphorylation of TAF7 and promotes metabolic reprogramming in injured epithelial cells and myofibroblasts.a Metabolomics analysis of kidney tissues from each group as indicated. Heatmap image showing relative levels of metabolites in the glycolysis pathway, fatty acid metabolism and Krebs cycle in kidneys from each group (n = 4). Bars represent statistical analysis of representative metabolites in kidneys of each group (mean ± SD, n = 4 mice of each group). One-way ANOVA followed by Tukey’s multiple comparisons test was used to determine the p-values. b Working model (the template was created with BioRender.com) illustrating in which DNA-PKcs mediates activation of Raptor/mTORC1 signaling through phosphorylation of TAF7 and promotes metabolic reprogramming in injured epithelial cells and myofibroblasts.

Notably, renal tubular-specific deletion of DNA-PKcs was also found to hamper the advancements of renal interstitial fibrosis in UUO. In vitro experiments revealed that DNA-PKcs deficiency was able to preserve the tubular epithelial cell phenotype and regulate interstitial fibroblast activation in vitro. These findings suggest that DNA-PKcs facilitate myofibroblast activation and epithelial de-differentiation without any direct link to lymphocyte deficiency.

The antifibrotic effects of NU7441, a highly specific DNA-PKcs inhibitor, were studied. In both UUO and UIR mouse models, NU7441 treatment was able to significantly attenuate the progression of renal interstitials. At physiological doses, NU7441 could partially inhibit DNA-PK.

Both in vivo and in vitro studies showed that DNA-PKcs deficiency did not exacerbate DSBs, indicating DNA-PKcs mediates renal injury and renal interstitial fibrosis. Furthermore, Phosphoproteomics analysis revealed a decreased phosphorylation of TAF7 in the kidney tissues of DNA-PKcs−/− mice. Interestingly, TAF7 deficiency blocked the profibrotic phenotype of fibroblasts and renal epithelial cells triggered by TGFβ1.

The profibrotic effects of TAF7 were almost entirely blocked by DNA-PKcs deficiency in renal epithelial cells. Our results indicate that TAF7 is a substrate for DNA-PKcs kinase activity and that DNA-PKcs-mediated phosphorylation of TAF7 aggravates renal fibrosis. ChIP assay showed that TAF7 can bind to the Rptor promoter directly, however, the underlying mechanism must be elucidated in future research. The authors pointed out that DNA-PKcs mediates the activation of RAPTOR/mTORC1 signaling through phosphorylation of TAF7.

Conclusions

DNA-PKcs activity was found to be undetectable in normal kidneys, in contrast to a significant increase during CKD. DNA-PKcs facilitates activation of RAPTOR/mTORC1 signaling via phosphorylation of TATA-box binding protein associated factor 7 (TAF7) in CKD. DNA-PKcs inhibition restores metabolic reprogramming in injured kidney cells, such as epithelial cells and myofibroblasts, in CKD. Hence, DNA-PKcs could be an important target for CKD treatment.

Tags: ActinCellChronicChronic Kidney DiseaseDialysisDNAFibrosisGenesGlycolysisGrowth Factorin vitroin vivoKidneyKidney DiseaseKinaseKnockoutLymphocyteMetabolitesmusclePhenotypePhosphorylationProteinRenal disease

Related Posts

Prenatal exposure to forever chemicals linked to higher teen blood pressure
Health

Prenatal exposure to forever chemicals linked to higher teen blood pressure

June 13, 2025
Meal and sleep timing play key roles in diabetes prevention
Health

Meal and sleep timing play key roles in diabetes prevention

June 13, 2025
Higher trust leads to greater happiness and life satisfaction
Health

Higher trust leads to greater happiness and life satisfaction

June 12, 2025
Updated EU CAR-T Handbook offers insights into latest developments in CAR-T cell therapies
Health

Updated EU CAR-T Handbook offers insights into latest developments in CAR-T cell therapies

June 12, 2025
Vape Package Warnings Can Deter Use, But Current Rules Are Lacking
Health

Vape Package Warnings Can Deter Use, But Current Rules Are Lacking

June 4, 2025
Exercise Cuts Colon Cancer Recurrence and Boosts Survival
Health

Exercise Cuts Colon Cancer Recurrence and Boosts Survival

June 4, 2025
Next Post
OpenAI presents GPT-4 – Latest version makes ChatGPT even smarter

OpenAI presents GPT-4 - Latest version makes ChatGPT even smarter

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: hello@sepoy.net

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • Gamble Texas hold em On line for real Currency Best six casino games for real money Sites out of 2025
  • Tiki queen of the nile $ Alice & The Mad Tea Party gokkast 1 stortin Wonders
  • Play casino All British no deposit bonus On the web Baccarat for real Money at best Us Casinos

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net